Heme Oxygenase-mediated Resistance to Oxygen Toxicity in Hamster Fibroblasts*

(Received for publication, August 13, 1996, and in revised form, February 28, 1997)

Phyllis A. Dennery Dagger , Kunju J. Sridhar , Christen S. Lee , Hubert E. Wong , Vida Shokoohi , Pamela A. Rodgers and Douglas R. Spitz §

From the Department of Pediatrics, Stanford University School of Medicine, Stanford, California 94305 and the § Department of Radiology, Cancer/Biology Section, Washington University, St. Louis, Missouri 63108

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

The role of heme oxygenase (HO)-1 was evaluated in the oxygen-resistant hamster fibroblast cell line, O2R95, which moderately overexpress HO when compared with the parental cell line, HA-1. To suppress HO-1 expression, O2R95 were transfected with HO-1 antisense oligonucleotide or treated with tin-mesoporphyrin (SnMP). To increase HO-1 expression, cells were transfected with HO-1 cDNA in a pRC/cytomegalovirus (CMV) vector. All cells were challenged with a 48-h exposure to 95% O2 (hyperoxia). When HO activity was suppressed, O2R95 cells had significantly decreased cell viability, increased susceptibility to lipid peroxidation, and increased protein oxidation in hyperoxia. In contrast, further overexpression of HO-1 did not improve resistance to oxygen toxicity. Antisense-transfected cells and SnMP-treated cells with lowered HO activity showed increased levels of cellular heme compared with controls. In the HO-1 cDNA-transfected O2R95 cells, cellular heme was lowered compared with controls; however, cellular redox active iron levels were increased. We conclude that HO mediates cytoprotection to oxygen toxicity within a narrow range of expression. We speculate that this protective effect may be mediated in part through increased metabolism of the pro-oxidant heme but that higher levels of HO activity obviate protection by increased redox active iron release.


INTRODUCTION

Heme oxygenase (HO-1),1 the rate-limiting enzyme in the conversion of heme to bilirubin, is known to be induced by various oxidant stresses. However, it is not clear whether HO serves in protection against hyperoxia and, if so, by which mechanisms. HO-1 antisense transfection experiments have shown that higher HO-1 protein levels were associated with protection against UVA radiation (1). Furthermore, transfection of coronary vessel endothelial cells with an overexpression vector containing HO-1 cDNA resulted in resistance against hemoglobin-induced injury (2). We have previously shown that HA-1 hamster fibroblasts made stably resistant to oxygen toxicity (O2R95) had 1.8-fold higher HO activity (3), suggesting that moderate increases in HO activity may be beneficial in resistance to oxygen toxicity. However, O2R95 cells have increases in other antioxidants that may also contribute to their resistance to oxygen toxicity (4), and no direct evidence currently exists linking HO to resistance to oxygen toxicity.

Investigators have hypothesized that HO may serve a role in protection against oxidative injury by forming the antioxidant molecules biliverdin and bilirubin (5, 6). Additionally, induction of ferritin with enhanced HO activity has been observed (1). This could lead to sequestration of redox active iron, thereby conferring protection against oxidative stress (7). Another possible antioxidant mechanism of HO could involve the destruction of heme itself. Heme and hemoproteins have been shown by several investigators to be instrumental in exacerbating oxidative injury (8, 9). This has lead to the hypothesis that reduction of the cellular heme pool by HO may diminish the interaction of heme with oxygen radicals or other reactive oxygen intermediates.

To investigate mechanisms by which HO-1 plays a causal role in resistance to oxygen toxicity, we examined the effect of reducing or increasing HO activity in O2R95 cells in the absence of nonspecific effects on other antioxidants believed to provide protection from oxygen toxicity. This was achieved by transfection with antisense oligonucleotides to HO-1 and HO-1 cDNA in a pRC/cytomegalovirus (CMV) overexpression vector, respectively. All transfected cells were also evaluated for levels of major cellular antioxidants other than HO and were not shown to demonstrate nonspecific effects.

Cells were then exposed to hyperoxia for 48 h, and cellular injury was measured by LDH release and Trypan Blue dye exclusion. Oxidative damage was assessed by measuring protein oxidation, glutathione depletion and susceptibility to lipid peroxidation as determined by formation of thiobarbituric acid reactive substances (TBA-RS). The injury response of the antisense-transfected cells was then compared with that of O2R95 cells transfected with sense or random oligonucleotides. To further corroborate the causal role of HO-1 in hyperoxic resistance, oxygen-resistant cells were treated with tin-mesoporphyrin (SnMP), a competitive inhibitor of HO, and exposed to hyperoxia for 48 h. Cellular injury and oxidative injury parameters were also assessed and compared with controls not treated with SnMP.

In all models of HO manipulation, the possible mechanism by which HO confers protection against oxygen toxicity were probed by comparing heme content and iron content of control and treated cells. This was done to determine whether accumulation of heme could explain increased oxidative injury when HO activity was suppressed and whether iron accumulation occurred with higher levels of HO activity.


EXPERIMENTAL PROCEDURES

Cell Line

A hamster fibroblast cell line with stable resistance to oxygen toxicity (O2R95) was used in all experiments. These cells have been extensively studied as to their antioxidant levels, growth characteristics, and morphology (4). O2R95 cells were isolated following chronic exposure (>200 days) of the HA-1 parental cell line to progressively increasing concentrations of oxygen (80-95%). O2R95 cells were then passaged in normoxia (up to 75 days) and were shown to maintain a stable oxygen-resistant phenotype, relative to HA-1 cells (4). Additionally, these cells are known to have increased levels of HO-1 and HO-2 protein as well as total HO activity compared with the parent cell line HA-1 (3).

Cell Culture Conditions

Hamster fibroblasts were grown in Eagle's minimum essential medium (MEM) supplemented with 10% fetal bovine serum (HyClone), glutamine (2 µmol), penicillin (100 units/ml), and streptomycin (100 µg/ml). The cells were grown in a 5% CO2 humidified atmosphere at 37 °C and maintained at subconfluency by passaging every 3-4 days with trypsin-EDTA. The cells were counted and 1 × 106 cells for each cell type was seeded in 75-mm2 flasks and allowed to proliferate for 3 days for experiments.

Transfection with Oligonucleotides

Upon attaining 50% confluence, cells were incubated in serum-free medium for 5 h. The cells were then transfected with HO-1 antisense oligonucleotides using a liposomal transfection reagent, DOTAP (Boehringer Mannheim). The oligonucleotides were comprised of the HO-1 transcription initiation codon and 6 base pairs on either side. Negative controls were the sense oligonucleotide, a complementary sequence to the antisense, and a random oligonucleotide, which comprised all of the base pairs of the antisense codon in random order. DOTAP and oligonucleotides were each prepared in HEPES buffer and then mixed at a ratio of 6:1. This ratio was determined in preliminary experiments to allow for optimal transfection efficiency in our system (data not shown). These two solutions were then combined and added to medium containing 0.5% serum, and this mixture was then added to the culture dishes. The cells were allowed to grow in the media containing oligonucleotides for a 24-h period. Thereafter, the complete growth medium was added, and the culture flasks were exposed to hyperoxia (95% oxygen, 5% CO2) for a 48-h period in a 37 °C humidified incubator. At 24-h intervals, the cells and media were collected for analysis. The 48-h time point was chosen in these experiments since it is known that no significant cellular injury occurs in O2R95 cells exposed to hyperoxia within this time frame (3).

Incubation with Tin-mesoporphyrin

In other experiments, cell cultures grown to 50-70% confluence were rinsed in Hank's balanced salt solution and incubated in Eagle's MEM supplemented with 1% fetal bovine serum (HyClone), glutamine (2 µmol), penicillin (100 units/ml), and streptomycin (100 µg/ml) and 10 µM tin-mesoporphyrin (Porphyrin Products, Logan UT) immediately prior to exposure to hyperoxia for 48 h, as described above. The metalloporphyrin solution was prepared in a darkened room, and the cell cultures were shielded from the light to obviate any potential photoreactivity of the metalloporphyrin.

Determination of HO Activity and Immunoreactive HO-1 Protein Levels

Cell homogenates were analyzed for HO activity by gas chromatography, as described previously (10), in subdued lighting. Homogenates were analyzed for protein content by the method of Bradford (11) and read at 595 nm.

Polyclonal rabbit anti-rat HO-1 antibodies were raised against a 30- kDa soluble HO-1 protein expressed in Escherichia coli from rat liver cDNA (12) (gift of Angela Wilks, University of California San Francisco, CA) by Berkeley Antibodies Inc., Berkeley, CA. as described previously (13). Rabbit anti-rat HO-2 were obtained from Stressgen (Vancouver, BC), and human ferritin antibodies were obtained from Sigma. For detection of HO-1 and HO-2 immunoreactive protein, 20-µg aliquots of cell sonicates were electrophoresed on a 12% polyacrylamide gel and incubated overnight with a 1:600 dilution of rabbit anti-rat HO-1 IgG. Antigen antibody complexes were visualized with the alkaline phosphatase chemiluminesence system according to the manufacturer instructions (Bio-Rad). Blots were subsequently washed in Tris-buffered saline with 0.1% Tween 20 overnight and reincubated for 2 h with a 1:800 dilution of rabbit anti-rat HO-2 IgG, and antigen antibody complexes were visualized as described above. For ferritin analysis, the Western method was modified in that a 15% gradient polyacrylamide gel (Bio-Rad) was used for electrophoresis, and a 1:1000 dilution of ferritin antibodies was incubated with the membranes for 2 h. In all gels, equal loading was verified by Coomassie Blue staining. Quantification of protein signal was performed by densitometry (PDI, Sunnyvale, CA). Additionally, to allow for normalization of ferritin protein signal between groups, quantification of Coomassie Blue-stained bands on the membranes was performed, and values for the antigen-antibody signal were expressed as a ratio of the membrane signal.

Immunohistochemical staining of HO-1 protein was accomplished with cells grown on glass slides to >80% confluence. The slides were washed in phosphate-buffered saline (PBS) and then fixed in ice-cold 100% acetone. The cells were permeabilized in 0.3% saponin in PBS and blocked in a PBS solution containing 5% milk, 1% bovine serum albumin, and 0.03% saponin. The slides were then incubated with a 1:25 dilution of rabbit anti-rat HO-1 antibodies overnight in a humidified chamber. After incubation, the slides were washed twice in PBS containing 0.03% saponin and 1% milk and further incubated with a 1:50 dilution of fluorescein isothiocyanate-conjugated goat anti-rabbit antibodies (Southern Biotechnologies Inc., Birmingham, AL) for 2 h at 37 °C. The slides were then mounted in phenylene diamine and viewed with an Axioskop fluorescent microscope (Zeiss, Germany) fitted with a 100-watt Mercury HBO100W/2 (Zeiss) lamp at excitation of 493 nm and photographed with a Nikon camera.

Determination of Cellular Injury

Cell culture medium was assayed for LDH release after hyperoxic exposure. In brief, samples of media (0.1 ml) were mixed with 0.2 mg NADH in 0.1 M KPO4 buffer and allowed to incubate for 10 min in a multiwell plate. Sodium pyruvate (2.3 µmol) was then added, and samples were read at 340 nm at 2 s intervals for 2 min. LDH concentration was calculated automatically from the slope of the absorbance curve with comparison to standard LDH enzyme solutions (Enzyme control 2-E, Sigma) (14). As another measure of cytotoxicity, cells were also stained with Trypan Blue and counted on a hematocytometer (>500 cells scored per sample). The percentage of cells that excluded Trypan Blue was used as an assessment of cell viability.

Determination of Oxidative Damage

Protein oxidation was estimated using Western analysis of protein carbonyl content by taking 4 volumes of the cell sonicates (a total of 20 µg of protein) in 2 volumes of 10% SDS buffer and reacting with 1 volume of 10 mM dinitrophenylhydrazine in trifluoroacetic acid for 30 min at room temperature. The samples were then neutralized by addition of 2 M Tris base, 30% glycerol (v/v), subjected to SDS-PAGE (15% gradient gels), and transblotted to PVDF membrane (Immobilon, Milipore). The blots were incubated with mouse monoclonal IgE anti-DNP antibody (Sigma) and then complexed to rat IgE anti-mouse HRP-labeled antibody (Southern Biotechnologies) and visualized by chemiluminescence (ECL kit, Amersham Corp.) (15). To compare the extent of protein oxidation, densitometric quantification of the band consistently showing the strongest signal in all samples was performed (PDI). Additionally, to allow for normalization of anti-DNP signal between groups, quantification of the Coomassie Blue-stained band on the membranes was performed, and values for the antigen-antibody signal was expressed as a ratio of the membrane signal.

Susceptibility to lipid peroxidation was assessed in cells scraped from flasks and incubated with buffer containing 50 µM ADP and 1 mM FeCl3 for 1 h at 37 °C. Thereafter, 0.3 ml of 10% trichloroacetic acid and 0.6 ml of 0.5% thiobarbituric acid (TBA) solution were added, and samples were boiled for 15 min. The samples were centrifuged at 5,000 × g, absorbance was read at 535 nm, and values were determined using an extinction coefficient of 1.55 × 10 M-1 cm-1 (16).

To ensure that the effect of antisense transfection was specific to HO-1 and did not result in altered levels of antioxidants, cellular antioxidants were measured 24 h after transfection. For total glutathione and antioxidant enzyme analysis, cells were washed twice with cold (4 °C) Puck's saline, scraped into cold saline, centrifuged at 400 × g, and the cell pellets were frozen at -80 °C. Frozen cell pellets were quickly thawed, 50 mM phosphate buffer containing 1.34 µM diethylentriaminepentaacetic acid was added, and the samples were sonicated for five bursts of 5 s each on ice. An aliquot of each sample was assayed for protein content by the method of Lowry, et al. (17). An aliquot of each sample was then mixed with 5% sulfosalicylic acid to obtain a diluted, protein-precipitated sample for determination of total glutathione using the method of Anderson (18) and expressed as micrograms of total GSH per milligrams of protein. The gamma -glutamyl transferase activity of samples was detected using a commercially available kit (Sigma 419). Glutathione S-transferase activity was determined by the methods of Simmons and Van der Jagt (19) using chlorodinitrobenzene as substrate. Glutathione peroxidase activity was assayed by the method of Lawrence and Burk (20) using cumene hydroperoxide as substrate. Catalase activity was determined by the method of Beers and Sizer (21) and expressed as kappa  units/mg of protein as described by Aebi (22). Superoxide dismutase activity was determined by the methods of Spitz and Oberley (23) and expressed as units per mg of protein. Cu,Zn superoxide dismutase activity was distinguished from Mn superoxide dismutase activity by the inhibition of the Cu,Zn superoxide dismutase activity with 5 mM sodium cyanide.

Determination of Heme and Iron Content

Heme content was determined in cell homogenates (20 µg of protein) solubilized in 2.5 ml of 1% cetyltrimethylammonium bromide in 0.2 N NaOH and scanned at absorbance 350-450 nm. The absorbance peak corresponding to the heme Sorret band (387.5 mm) was quantitated by comparing to an external standard (hemin, Sigma) (24).

Hemoprotein content was determined using a modification of the method of Bonfils et al. (25). Protein samples (300 µg) were boiled for 2 min in 50 mM Tris-HCl buffer, pH 8.9, containing 10% glycerol, 1% lithium dodecyl sulfate (LDS), and 0.1% pyronin Y. The samples were then electrophoresed on a 15% LDS-polyacrylamide gel at 200 V in LDS electrophoretic buffer. After electrophoresis, the gel was incubated with a solution containing 0.1 M luminol in Me2SO, 0.02 M 4-iodophenol in Me2SO, and 30 µl of 30% H2O2 in 7 ml of PBS, pH 7.4, for 5 min. The gel was then briefly washed in PBS and visualized using an intensified CCD camera (Hamamatsu). The camera was fitted with a 60-mm macro lens, and images were processed using an Aegus 50 image processor (Hamamatsu) and archived on a 486 IBM workstation. Grayscale images representing photon emission were obtained by integrating over 5 min. The images were transferred to a Macintosh Power PC and superimposed using Adobe Photoshop Software. Images were displayed at a bit range of 0-3.

Free iron was estimated by the ferrozine method (26). Samples were mixed with 100% trichloroacetic acid in the presence of 0.02% ascorbic acid in 0.1 N HCl. Thereafter, 10% ammonium acetate and 0.1 ml of ferrozine solution in water were added, and the color was developed over 5 min at room temperature measured at 562 nm. The iron concentration was calculated using an extinction coefficient of 27.9.

Statistical Analysis

In the antisense transfection to allow for comparisons and normalization between experiments, values were expressed as a ratio of an untransfected control for each experiment. In the vector transfected cells, a sham control was used for comparisons, and the data were normalized to this control. In the SnMP experiments, results were not normalized to an internal control. For comparison between treatment groups, the null hypothesis that there was no difference between treatment means was tested by a single factor analysis of variance for multiple groups or unpaired t test for two groups (Statview 4.02, Abacus Concepts, Inc., Berkeley, CA). Statistical significance (p < 0.05) between and within groups was determined by means of the Fischer method of multiple comparisons.


RESULTS AND DISCUSSION

Total HO Activity and HO-1 Protein in Antisense-transfected O2R95 Cells

The O2R95 demonstrate a stable oxygen-resistant phenotype following chronic (>200 days) passage in high oxygen (4) and also have constitutively higher levels of HO activity than do parent cell lines (3). Although these cells differ from the parent cell line in other respects specifically, lowering HO activity in the O2R95 would be predicted to increase sensitivity to oxygen toxicity if increased HO activity plays a causal role in antioxidant defense. Since no HO-1 induction occurs in O2R95 cells within 48 h of hyperoxia (3), no increased HO activity should be noted that could obviate the inhibitory effects of antisense oligonucleotides within this time period. Cells transfected with HO-1 antisense oligonucleotides showed a 28% decrease in total HO activity compared with sense and random treated controls (Fig. 1), and HO-1 protein was decreased to 55% of controls when expressed as a ratio of HO-1/HO-2 for normalization (Fig. 2A). The latter was a valid calculation since HO-2 did not change in hyperoxia (Fig. 2B).


Fig. 1. Total HO activity in transfected cells exposed to hyperoxia. HO activity in cell homogenates was determined by gas chromatography allowing for the detection of CO. The clear bar (A) represents antisense-transfected cells, the hatched bar (S)represents sense controls, the gray bars (R) represent random transfected cells, and the solid bars (V) represent the HO-1 cDNA transfected cells. *, p < 0.05 versus controls. Values are expressed as mean ± S.E. of six experiments.
[View Larger Version of this Image (27K GIF file)]


Fig. 2. A, ratio of HO-1/HO-2 protein in antisense-transfected cells exposed to hyperoxia. HO protein levels were determined in cell sonicates by Western analysis, and the protein signal was quantified by densitometry. The values for HO-1 and HO-2 in the same membrane were expressed as a ratio to allow for normalization of the HO-1 signal. The clear bar (A) represents antisense-transfected cells, the hatched bar (S) represents sense controls, the gray bars (R) represent random transfected cells, and the solid bars (V) represent the HO-1 cDNAtransfected cells. *, p < 0.05 versus controls. Values are expressed as mean ± S.E. of six experiments. B, representative example of detection of immunoreactive HO-2 protein in transfected cells exposed to hyperoxia. HO-2 protein levels were determined in cell sonicates by Western analysis. Lane C, positive control, adult brain; lane A, antisense-transfected cells; lane S, sense-transfected cells; lane R, random transfected cells, and lane V, HO-1 cDNA-transfected cells. Equal loading of the experimental samples was verified with Coomassie Blue.
[View Larger Version of this Image (27K GIF file)]

The effect of antisense transfection on other antioxidants was also assessed to better understand the effect of this technique on susceptibility to hyperoxic injury. A small but significant elevation in total glutathione content was observed with HO-1 antisense transfection prior to hyperoxic exposure. None of the other measured antioxidant enzymes were modified by antisense transfection (Table I).

Table I. Antioxidants in transfected O2R95 cells

The abbreviations used in the table are: gamma -GT, gamma -glutamyl transferase; GPX, glutathione-peroxidase; GST, glutathione S-transferase; CAT, catalase; SOD, superoxide dismutase.

Antioxidant Antisense Sense Random HO-1 cDNA

GSHa 5.23  ± 0.20b 4.52  ± 0.07 4.21  ± 0.07 5.76  ± 0.36c
 gamma -GTd 1.39  ± 0.06 1.35  ± 0.09 1.22  ± 0.1 1.07  ± 0.21
GPXe 45.33  ± 0.23 41.03  ± 2.62 39.07  ± 1.15 44.2  ± 2.1
GSTd 547.67  ± 15.07 538  ± 17.32 477  ± 30.04 581.33  ± 21.3
CATf 976  ± 88 916.33  ± 42.53 914  ± 40.39 1260  ± 87.9c
Total SODd 201.33  ± 11.56 188  ± 6 224  ± 14.47 205.67  ± 24.13
Cu,Zn-SODd 168.33  ± 12.92 160.33  ± 5.81 195.33  ± 15.32 183  ± 25.58
Mn-SODd 33.33  ± 4.33 27.67  ± 2.4 28.67  ± 2.03 22.67  ± 1.45

a µg/mg of protein.
b p < 0.05 versus sense or random control.
c p < 0.05 versus sham-transfected control.
d Units/mg of protein.
e Milliunits/mg of protein.
f kappa units/mg of protein.

Evaluation of Cellular Injury

Antisense transfection led to significantly decreased resistance to oxygen toxicity. After hyperoxic exposure, cells treated with antisense oligonucleotides had a 1.8- and 1.7-fold increase in LDH release compared with sense or random transfected controls, respectively (Fig. 3A) and significantly decreased cell viability compared with sense and random transfected controls, respectively (Fig. 3B). More specific markers of oxidant injury were also assessed. After 48 h of hyperoxic exposure, antisense-transfected cells showed lower levels of total glutathione than sense or random transfected controls (83% of sense and 77% of random) (Fig. 4). Protein oxidation, as determined by protein carbonyl content, increased 2.02- and 1.81-fold in antisense-transfected cells exposed to hyperoxia compared with sense and random controls, respectively (Fig. 5). Furthermore, susceptibility to TBA-RS formation was increased 1.9- and 2.5-fold in antisense-transfected hamster fibroblasts compared with sense and random transfected controls, respectively (Fig. 6). These results strongly support the hypothesis that the oxygen-resistant phenotype noted in the O2R95 cells is in part causally related to the modified HO-1 protein and activity in these cells compared with the parent cells. These results are also consistent with the observations of Vile et al. (2), which show, using antisense transfection, that lowering HO-1 protein altered resistance to UVA radiation. However, no reports to date have documented a causal link between decreased HO-1 protein or decreased HO activity on resistance to oxygen toxicity, further suggesting that HO is important in physiological antioxidant defenses.


Fig. 3. A, relative LDH release in transfected cells exposed to hyperoxia. The clear bars (A) represent antisense-transfected cells, the hatched bars (S) represent sense controls, the gray bars (R) represent random transfected cells, and the solid bars (V) represent the HO-1 cDNA-transfected cells. *, p < 0.05 versus controls. Values are expressed as mean ± S.E. of six experiments. B, relative cell viability in transfected cells exposed to hyperoxia as determined by Trypan Blue exclusion. The clear bars (A) represent antisense-transfected cells, the hatched bars (S) represent sense controls, the gray bars (R) represent random transfected cells, and the solid bars (V) represent the HO-1 cDNA-transfected cells. *, p < 0.05 versus sense control; dagger , p < 0.05 versus random control. Values are expressed as mean ± S.E. of nine experiments.
[View Larger Version of this Image (26K GIF file)]


Fig. 4. Total glutathione content in transfected cells exposed to hyperoxia. The clear bars (A) represent antisense-transfected cells, the hatched bars (S) represent sense controls, the gray bars (R) represent random transfected cells, and the solid bars (V) represent the HO-1 cDNA-transfected cells. *, p < 0.05 versus controls. Values are expressed as mean ± S.E. of four experiments.
[View Larger Version of this Image (26K GIF file)]


Fig. 5. A, shown is a representative of six Western analyses of protein carbonyls detected with anti-DNP antibodies in antisense-transfected cells. Lane U, negative control, cells not treated with an oxidizing agent; lane O, positive control, cells treated with ascorbic acid and ferric chloride for 4 h to cause oxidative damage; lane A, antisense-transfected cells; lane S, sense-transfected cells; lane R, random transfected cells, and lane V, HO-1 cDNA-transfected cells. Equal loading of the experimental samples was verified with Coomassie Blue. B, densitometric quantitation of the protein carbonyl content of transfected cells exposed to hyperoxia. The clear bars (A) represent antisense-transfected cells, the hatched bars (S) represent sense controls, the gray bars (R) represent random transfected cells, and the solid bars (V) represent the HO-1 cDNA-transfected cells. *, p < 0.05 versus sense control; dagger , p < 0.05 versus random control. Values are derived from the Western analyses illustrated in panel A) and expressed as mean ± S.E. of six experiments.
[View Larger Version of this Image (24K GIF file)]


Fig. 6. TBA-RS formation in transfected cells exposed to hyperoxia and incubated with FeCl3 and ADP for 1 h (see "Experimental Procedures"). The clear bars (A) represent antisense-transfected cells, the hatched bars (S) represent sense controls, the gray bars (R) represent random transfected cells, and the solid bars (V) represent the HO-1 cDNA-transfected cells. *, p < 0.05 versus controls. Values are expressed as mean ± S.E. of six experiments.
[View Larger Version of this Image (24K GIF file)]

Effect of Overexpression of HO-1 in O2R95 Cells

Others have investigated the effects of transfection of HO-1 cDNA in other models of injury. A 3-fold increase in HO activity resulted in cytoprotection against heme-mediated injury (2). If lowered HO activity is associated with lowered resistance to oxygen toxicity and overexpression of HO is associated with improved resistance to oxygen toxicity, as previously suggested (3), we hoped to further improve oxygen resistance in the O2R95 cells by further increasing HO activity with transfection with HO-1 cDNA in a prC/CMV overexpression vector. With this strategy, HO activity and HO-1 protein were 1.8- and 2.3-fold higher, respectively, in the transfected O2R95 than in the O2R95 controls (Fig. 1), whereas HO-1 protein was increased 2.3-fold in the HO-1 cDNA-transfected cells compared with sham-transfected controls (Fig. 2A), and no changes in HO-2 protein were noted (Fig. 2B). The latter observation was further corroborated with immunohistochemistry where HO-1 protein was visibly increased in the HO-1-cDNA transfected cells compared with sham-transfected controls (data not shown). Therefore, we could assume that the HO-1 cDNA transfected cells had approximately a 4-fold increase in HO activity compared with HA-1 parent cells. However, the transfected cells did not show any further protection against oxygen toxicity despite relatively higher total GSH and catalase levels than controls (Table I). There was no decrease in LDH release in HO-1 cDNA transfected cells exposed to hyperoxia compared with controls (Fig. 3A). Additionally, no changes in total glutathione (Fig. 4) and in susceptibility to TBA-RS formation (Fig. 6) were associated with overexpression of HO-1. In fact, in some instances, deleterious effects were observed with overexpression of HO-1. There was a significant loss of cell viability (Fig. 3B), and protein oxidation was increased 1.67-fold (Fig. 5, A and B) in HO-1 cDNA-transfected cells compared with sham-transfected controls after hyperoxic exposure. This seemingly paradoxical effect may be similar to what is observed with other antioxidants, albeit within a tighter range. For example, maximal overexpression of Cu,Zn superoxide dismutase results in increased rather than decreased toxicity compared with moderate overexpression (27). Perhaps HO serves as an antioxidant in oxygen toxicity but only within a narrow range of HO expression.

Evaluation of Heme, Iron, and Ferritin

To begin to better understand how HO mediates antioxidant effects, we examined heme and iron contents in all experimental conditions. We hypothesized that heme regulation by HO may allow for lowering of this known pro-oxidant. Several investigators have shown that heme is an oxidant in several model systems (8, 9). Furthermore, it was recently demonstrated that HO-1 overexpression can protect against exogenously provided heme (2). However, it is not known whether HO sufficiently modifies endogenous heme levels to alter outcome of oxidative injury in hyperoxia, especially in a cell culture model where no exogenous heme has been provided. Heme content of antisense-transfected cells was approximately 1.5-fold higher than that of sense or random transfected cells (Fig. 7) and was 63% lower in the HO-1 overexpressing O2R95 cells compared with sham-transfected controls (Fig. 7). Iron, a by-product of the HO metabolic pathway, is a known potent oxidant which can interact with reactive oxygen species and lead to further oxygen radical generation (28-30). Total cellular iron content was 1.5-fold higher in the antisense-transfected cells compared with sense-transfected cells, but this did not achieve statistical significance (Fig. 8). In contrast, iron content was 1.7-fold higher in O2R95 after HO-1 cDNA transfection (Fig. 8). We speculate that heme and iron regulation mediated by HO may be even more relevant to protection against oxidative injury in clinical circumstances where heme is found in abundance. Since further overexpresssion of HO did not provide further benefits against hyperoxic injury, perhaps the higher cellular iron content seen in HO-1 cDNA-transfected cells abrogated the beneficial antioxidant effects of HO-1-transfected cells.


Fig. 7. Heme content in transfected cells exposed to hyperoxia. The clear bars (A) represent antisense-transfected cells, the hatched bars (S) represent sense controls, the gray bars (R) represent random transfected cells, and the solid bars (V) represent the HO-1 cDNA-transfected cells. *, p < 0.05 versus controls. Values are expressed as mean ± S.E. of three experiments.
[View Larger Version of this Image (23K GIF file)]


Fig. 8. Iron content in transfected cells exposed to hyperoxia. The clear bars (A) represent antisense-transfected cells, the hatched bars (S) represent sense controls, the gray bars (R) represent random transfected cells, and the solid bars (V) represent the HO-1 cDNA-transfected cells. *, p < 0.05 versus controls. Values are expressed as mean ± S.E. of three experiments.
[View Larger Version of this Image (21K GIF file)]

Effect of Incubation of O2R95 with SnMP

To further corroborate that changing HO activity results in changes in oxygen resistance in the O2R95 cells, these were incubated with SnMP, a competitive inhibitor of HO. This compound was chosen since it has been used in clinical trials in human neonates without adverse effects (31), and it lowers HO activity effectively without induction of HO-1 mRNA or changes in HO-1 protein within 48 h, as with other metalloporphyrins (32). Cells incubated with 10 µM SnMP showed a significant decrease in total HO activity compared with untreated controls (65 ± 3% of control; p < 0.05 in a total of 3 experiments in each group). Although HO activity changed with SnMP incubation, HO-1 or HO-2 protein content did not change (Fig. 9).


Fig. 9. Representative of six Western analyses of HO-1 (upper band) and HO-2 (lower band) immunoreactive protein in SnMP-treated cells. Lane C, positive control, liver from CoCl-treated adult rat for HO-1 or adult rat brain for HO-2; lane OC, control, oxygen exposed cells; lane OS, SnMP-treated oxygen-exposed cells. Equal loading of the experimental samples was verified with Coomassie Blue.
[View Larger Version of this Image (61K GIF file)]

As with antisense transfection, incubation of O2R95 with SnMP and subsequent exposure to hyperoxia resulted in loss of resistance to oxygen toxicity. In the SnMP-treated cells, we noted decreased cell viability as assessed by Trypan Blue dye exclusion (80.1 ± 3 versus 95.1 ± 2%; mean of five experiments; p < 0.05), glutathione depletion (3.3 ± 0.01 versus 5.35 ± 0.04 µg/mg of protein; mean of four experiments; p < 0.05), and increased susceptibility to lipid peroxidation (34.02 ± 3.5 versus 13.58 ± 4.4 nmol/mg of protein; mean ± S.E. of 5 groups, p < 0.05) but, surprisingly, no increased LDH release compared with the antisense-transfected cells. This could not be attributed to a direct effect of SnMP on the LDH assay since we did not observe a reduction in LDH with addition of SnMP to samples. In addition, although hyperoxic exposure alone resulted in increased protein oxidation compared with air controls (relative densitometric units of 0.48 ± 0.05 versus 0.25 ± 0.03 mean ± S.E. of three experiments; p < 0.05), incubation with SnMP did not further increase protein oxidation (0.48 ± 0.05 versus 0.53 ± 0.03; mean ± S.E. of three experiments). These differences may be due to cellular effects of SnMP since this agent may be metabolized by the cells and may inhibit or alter other enzymes or cellular functions (33). Nonetheless, these experiments are consistent with the antisense transfection experiments, where only HO-1 was altered, and demonstrate that lowering HO activity increases susceptibility to oxygen toxicity.

As with the transfection experiments, we wanted to evaluate the role of heme and iron in the protective role of HO using this model. However, SnMP absorbs at 387 nm. Therefore, detection of the heme peak would be altered in the presence of SnMP. We alternatively evaluated heme and hemoprotein content of cells by chemiluminescent detection. Using this technique, SnMP-treated cells exposed to hyperoxia had visibly higher heme and hemoprotein content than untreated hyperoxia exposed controls (Fig. 10). SnMP alone did not result in luminescence. In hyperoxia, SnMP treated cells had a 1.9-fold increase in total cellular iron compared with untreated controls exposed to hyperoxia (2.79 ± 0.54 versus 1.48 ± 0.53 µg/mg protein, mean ± S.E. of four experiments, p < 0.05). This could not be explained by interference of SnMP with the ferrozine reaction. These results further corroborate that degradation of heme and accumulation of iron may play a significant role in HO-mediated cytoprotection.


Fig. 10. Representative of 4 polyacrylamide gels treated with luminol for the detection of hemoproteins in O2R95 cells incubated with 10 µM SnMP and exposed to hyperoxia (see "Experimental Procedures"). The images represent an inversed pixelated image of the photonic emission collected from the electrophoresed protein samples by a CCD camera. Lane 1, negative control, 300 µg albumin; lanes 2-6, positive controls, cytochrome c (10 µg), hemoglobin (40 µg), lactate dehydrogenase (20 µg), myoglobin (40 µg); lane OC, control, oxygen exposed cells; and lane OS, SnMP-treated oxygen-exposed cells. Equal loading of the experimental samples was verified with Coomassie Blue. The lower band in each lane (arrow) represents free heme migrating with the dye front.
[View Larger Version of this Image (29K GIF file)]

Effect of HO Expression on Ferritin Protein Levels

In many model systems, iron (34, 35) and increased HO activity (35, 36) have been shown to regulate ferritin. It is thought that increased ferritin content serves to sequester redox active iron, thereby enhancing protection against oxidative stress (7). However, in certain circumstances, ferritin can also contribute iron to exacerbate oxidative injury (37). Antisense transfection did not alter ferritin protein (relative densitometric units of 0.76 ± 0.19 for antisense versus 0.72 ± 0.13 for sense and 0.85 ± 0.19 for random transfected; no significant differences between groups, values represent the mean ± S.E. of four experiments). Nor did overexpression of HO-1 result in changes in ferritin protein levels (relative densitometric units are 0.91 ± 0.16 of sham-transfected control, values represent mean ± S.E. of four experiments). Furthermore, treatment with SnMP also did not affect ferritin expression (relative densitometric units of 0.51 ± 0.1 versus 0.68 ± 0.13; mean ± S.E. of three experiments), despite changes in HO activity and iron content. Finally, as in previous studies, hyperoxia alone did not alter ferritin levels in the O2R95 cells (3). Perhaps the cells had sufficient levels of ferritin and, therefore, did not need to induce it further, or it may be that, in the time interval measured, ferritin protein did not change sufficiently to be detected. In this model, we suspect that HO mediates its protective effects by other mechanisms than enhanced ferritin expression.

In summary, using antisense transfection, we have shown that lowering HO activity in oxygen-resistant cells O2R95, with constitutive overexpression of HO, is causally associated with marked lowering of resistance to hyperoxia. Additionally, we have shown that a further increase in HO-1 protein and HO activity in these cells with constitutively high HO activity does not provide additional benefits in resistance to hyperoxia. We conclude that HO serves to ameliorate resistance to oxygen toxicity within a narrow range of expression. We speculate that the antioxidant effects of HO-1 are related to its heme-lowering effects. However, with excessive HO activity, cellular iron may accumulate, thereby negating the beneficial antioxidant properties of HO.


FOOTNOTES

*   This work was supported by National Institutes of Health Grants HL52701 ( to P. A. D.) and HL51469 (to D. R. S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    To whom correspondence should be addressed: Dept. of Pediatrics, Stanford University School of Medicine, 750 Welch Rd., #315, Palo Alto, CA 94304. Tel.: 415-723-5711; Fax: 415-725-8351; E-mail: mn.phd{at}forsythe.stanford.edu.
1   The abbreviations used are: HO, heme oxygenase; SnMP, tin-mesoporphyrin; TBA, thiobarbituric acid; TBA-RS, TBA-reactive substances; LDH, lactate dehydrogenase; PBS, phosphate-buffered saline; LDS, lithium dodecyl sulfate; CMV, cytomegalovirus; DOTAP, n-[1-(2,3-dioleoyloxy)propyl]-n,n,n-trimethylammonium methylsulfate.

ACKNOWLEDGEMENTS

We are grateful to Dr. Christopher H. Contag for assistance with the CCD camera. We thank Julia Sim and Shelley Wetsell for expert technical assistance. We also thank Tonya Gonzales and Tiffany Haas for secretarial support.


REFERENCES

  1. Vile, G. F., Basu-Modak, S., Waltner, C., and Tyrrell, R. M. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 2607-2610 [Abstract]
  2. Abraham, N. G., Lavrovsky, Y., Schwartzman, M. L., Stoltz, R. A., Levere, R. D., Gerritsen, M. E., Shibahara, S., and Kappas, A. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 6798-6802 [Abstract]
  3. Dennery, P. A., Wong, H. E., Sridhar, K. J., Rodgers, P. A., Sim, J. E., and Spitz, D. R. (1996) Am. J. Physiol. 271, L672-L679 [Abstract/Free Full Text]
  4. Sullivan, S. J., Oberley, T. D., Roberts, R. J., and Spitz, D. R. (1992) Am. J. Physiol. 262, L748-L756 [Abstract/Free Full Text]
  5. Maines, M. D. (1988) FASEB J. 2, 2557-2568 [Abstract/Free Full Text]
  6. Llesuy, S. F., and Tomaro, M. L. (1994) Biochim. Biophys. Acta 1223, 9-14 [Medline] [Order article via Infotrieve]
  7. Balla, G., Jacob, H. S., Balla, J., Rosenberg, M., Nath, K., Apple, F., Eaton, J. W., and Vercellotti, G. M. (1992) J. Biol. Chem. 267, 18148-18153 [Abstract/Free Full Text]
  8. Balla, J., Jacob, H. S., Balla, G., Nath, K., Eaton, J. W., and Vercellotti, G. M. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 9285-9289 [Abstract]
  9. Vercellotti, G. M., Balla, G., Balla, J., Nath, K., Eaton, J. W., and Jacob, H. S. (1994) Artif. Cells Blood Substit. Immobil. Biotechnol. 22, 207-213 [Medline] [Order article via Infotrieve]
  10. Vreman, H. J., and Stevenson, D. K. (1988) Anal. Biochem. 168, 31-38 [Medline] [Order article via Infotrieve]
  11. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254 [CrossRef][Medline] [Order article via Infotrieve]
  12. Wilks, A., and Ortiz de Montellano, P. R. (1993) J. Biol. Chem. 268, 22357-22362 [Abstract/Free Full Text]
  13. Rodgers, P. A., Seidman, D. S., Wei, P. L., Dennery, P. A., and Stevenson, D. K. (1996) Pediatr. Res. 39, 1041-1049 [Abstract]
  14. Monyer, H., Goldberg, M. P., and Choi, D. W. (1989) Brain Res. 483, 347-354 [Medline] [Order article via Infotrieve]
  15. Schacter, E., Williams, J. A., Lim, M., and Levine, R. L. (1994) Free Radical Biol. & Med. 17, 429-437 [CrossRef][Medline] [Order article via Infotrieve]
  16. Wright, J. R., Colby, H. D., and Miles, P. R. (1981) Arch. Biochem. Biophys. 206, 296-304 [Medline] [Order article via Infotrieve]
  17. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) J. Biol. Chem. 193, 265-275 [Free Full Text]
  18. Anderson, M. E. (1985) Methods Enzymol. 113, 548-555 [Medline] [Order article via Infotrieve]
  19. Simons, P. C., and Vander Jagt, D. L. (1977) Anal. Biochem. 82, 334-341 [Medline] [Order article via Infotrieve]
  20. Lawrence, R. A., and Burk, R. F. (1976) Biochem. Biophys. Res. Commun. 71, 952-958 [Medline] [Order article via Infotrieve]
  21. Beers, R. F., and Sizer, I. W. (1952) J. Biol Chem. 195, 133-140 [Free Full Text]
  22. Aebi, H. (1984) Methods Enzymol. 105, 121-126 [Medline] [Order article via Infotrieve]
  23. Spitz, D. R., and Oberley, L. W. (1989) Anal. Biochem. 179, 8-18 [Medline] [Order article via Infotrieve]
  24. Christensen, T., Sandquist, T., Feven, K., Waksvik, H. J., and Moan, J. (1983) Br. J. Cancer 48, 35-43 [Medline] [Order article via Infotrieve]
  25. Bonfils, C., Charasse, S., Bonfils, J. P., and Larroque, C. (1995) Anal. Biochem. 226, 302-306 [CrossRef][Medline] [Order article via Infotrieve]
  26. Carter, P. (1971) Anal. Biochem. 40, 450-458 [Medline] [Order article via Infotrieve]
  27. Nelson, S. K., Bose, S. K., and McCord, J. M. (1994) Free Radical Biol. & Med. 16, 195-200 [CrossRef][Medline] [Order article via Infotrieve]
  28. Balla, G., Vercellotti, G. M., Eaton, J. W., and Jacob, H. S. (1990) J. Lab. Clin. Med. 116, 546-554 [Medline] [Order article via Infotrieve]
  29. Aust, S. D., Miller, D. M., and Samokyszyn, V. M. (1990) Methods Enzymol. 186, 457-463 [Medline] [Order article via Infotrieve]
  30. Minotti, G., and Aust, S. D. (1992) Lipids 27, 219-226 [Medline] [Order article via Infotrieve]
  31. Valaes, T., Petmezaki, S., Henschke, C., Drummond, G. S., and Kappas, A. (1994) Pediatrics 93, 1-11 [Abstract]
  32. Dennery, P. A., Rodgers, P. A., Sullivan, T. M., and Stevenson, D. K. (1996) J. Invest. Med. 44, 114 (abstr)
  33. Ny, L., Andersson, K. E., and Grundemar, L. (1995) Br. J. Pharmacol. 115, 186-190 [Abstract]
  34. Coccia, E. M., Stellacci, E., Perrotti, E., Marziali, G., and Battistini, A. (1994) J. Biol. Regul. Homeostatic Agents 8, 81-87
  35. Eisenstein, R. S., Garcia, M. D., Pettingell, W., and Munro, H. N. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 688-692 [Abstract]
  36. Vile, G. F., and Tyrrell, R. M. (1993) J. Biol. Chem. 268, 14678-14681 [Abstract/Free Full Text]
  37. Reif, D. W. (1992) Free Radical Biol. & Med. 12, 417-27 [CrossRef][Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.